Enhancing Cell Line Development:
Viability & IgG Detection with Cyto-Cellect®
Discover how to accelerate your cell line development and antibody discovery workflows!
In this expert-led session, we explore how the Cyto-Cellect® Human IgG Kappa and Viability Assay Kit, helps you rapidly identify high-producing antibody-secreting cells while excluding non-viable ones—ensuring you select only the best candidates.
Whether you are optimizing cell line development or streamlining antibody discovery, this webinar provides actionable insights to enhance efficiency and confidence in your results.
In this webinar to learn how to:
Register Now!
Join our expert, Ben Duckless, Senior Field Application Scientist, guide you through the science, best practices, and real-world applications of this innovative assay.
Meet Our Expert
Ben Duckless
Senior Field Application Scientist
With a background in life sciences, Ben brings extensive expertise in supporting researchers to optimize workflows for antibody discovery, cell line development, and therapeutic screening.
Specializing in single-cell analysis and functional screening technologies. Ben holds a degree from the University of New Hampshire’s College of Life Sciences and Agriculture. His career spans roles in scientific applications and technical support, where he has helped scientists leverage cutting-edge microfluidics and picodroplet-based platforms to accelerate their research.
At Sphere Bio, Ben plays a key role in demonstrating the capabilities of Cyto-Mine® Chroma, ensuring customers maximize the benefits of high-throughput, multiplexed single-cell screening. His recent thought leadership includes insights on how multiplexing enhances precision in cell selection, driving efficiency and innovation in biopharmaceutical development.
